The ADAP Advocacy Association (aaa+®) issued the following press releases:
Announcement made during U=U Global Summit in Montreal
WASHINGTON, D.C. (August 1, 2022) - The ADAP Advocacy Association (aaa+®) today applauded the governments of the United States and Canada for formally supporting the science behind and messaging for Undetectable = Untransmittable (U=U). U=U fortifies that people living with HIV who are taking their medication and have an undetectable viral load can’t spread HIV sexually. The U=U Campaign, spearheaded by the Prevention Access Campaign (PAC), has been widely recognized as a transformative message, and now the U.S. and Canadian governments have joined the U=U chorus.
WASHINGTON, D.C. (July 19, 2022) - The Board of Directors for the ADAP Advocacy Association (aaa+®) and the Community Access National Network (CANN) issued the following joint statement in response to the news about Edward "Eddie" Hamilton’s passing on Tuesday, July 12th.
S.4395 would divert limited resources away from care to prevention
WASHINGTON, D.C. (July 13, 2022) - The ADAP Advocacy Association (aaa+®) today expressed strong opposition to raiding the Ryan White HIV/AIDS Program (RWHAP) to fund prevention programs, including access to pre-exposure prophylaxis. For over thirty years, RWHAP has served as the nation’s only public health program solely dedicated to providing support and services to people living with HIV/AIDS (PLWHA). Instead, other programs that already exist for prevention services should be strengthened and better funded.
Highlighting its Commitment to Access, Information & Participation
WASHINGTON, D.C. (May 3, 2022) - The ADAP Advocacy Association (aaa+®) today released its 2021 Annual Report – which highlights the organization’s ongoing commitment to access, information and participation for patient advocacy designed to promote and protect the AIDS Drug Assistance Program (“ADAP”). The report is shared using an infographic format to capture the previous year’s highlights.
Highlights important steps patients living with HIV/AIDS can take to protect themselves against counterfeit HIV medicines
WASHINGTON, D.C. (March 14, 2022) - The ADAP Advocacy Association (aaa+®) today aired its Public Service Announcement designed to raise awareness about the dangers of counterfeit drugs. The PSA comes in response to Gilead Sciences recently warning patients living with HIV/AIDS about counterfeit HIV medication being distributed in the United States.
Retreats designed to assemble key stakeholder groups to discuss pertinent issues facing people living with HIV/AIDS
WASHINGTON, D.C. (February 10, 2022) - The ADAP Advocacy Association (aaa+®) today announced it would resume its face-to-face advocacy starting later this year, after a two-year pause in response to the Covid-19 pandemic.